Endo International PLC (NASDAQ:ENDP) was the recipient of a large growth in short interest in September. As of September 15th, there was short interest totalling 16,003,377 shares, a growth of 16.7% from the August 31st total of 13,712,139 shares. Approximately 8.0% of the shares of the company are sold short. Based on an average trading volume of 4,829,498 shares, the short-interest ratio is currently 3.3 days.
ENDP has been the topic of several recent analyst reports. Vetr raised Endo International PLC from a “hold” rating to a “buy” rating and set a $21.95 target price on the stock in a research note on Thursday, August 25th. Mizuho reaffirmed a “buy” rating and set a $29.00 target price on shares of Endo International PLC in a research note on Monday, September 19th. Morgan Stanley set a $16.00 target price on Endo International PLC and gave the company a “hold” rating in a research note on Thursday, September 8th. Leerink Swann reaffirmed a “market perform” rating and set a $23.00 target price on shares of Endo International PLC in a research note on Wednesday, June 29th. Finally, JMP Securities reaffirmed a “buy” rating on shares of Endo International PLC in a research note on Wednesday, June 29th. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and eleven have issued a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $37.50.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in ENDP. Heartland Advisors Inc. bought a new position in Endo International PLC during the second quarter worth $15,627,000. State Street Corp increased its position in Endo International PLC by 9.3% in the second quarter. State Street Corp now owns 9,430,866 shares of the company’s stock worth $147,021,000 after buying an additional 805,101 shares in the last quarter. Schneider Capital Management Corp bought a new position in Endo International PLC during the second quarter worth $6,941,000. Quantitative Investment Management LLC increased its position in Endo International PLC by 166.2% in the second quarter. Quantitative Investment Management LLC now owns 654,800 shares of the company’s stock worth $10,208,000 after buying an additional 408,800 shares in the last quarter. Finally, Alps Advisors Inc. bought a new position in Endo International PLC during the second quarter worth $4,877,000. 96.64% of the stock is owned by hedge funds and other institutional investors.
Shares of Endo International PLC (NASDAQ:ENDP) opened at 20.15 on Friday. The firm’s market cap is $4.49 billion. Endo International PLC has a 12 month low of $12.56 and a 12 month high of $72.85. The firm has a 50 day moving average price of $21.39 and a 200-day moving average price of $21.13.
Endo International PLC (NASDAQ:ENDP) last released its earnings results on Monday, August 8th. The company reported $0.86 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.74 by $0.12. Endo International PLC had a negative net margin of 25.90% and a positive return on equity of 15.54%. The firm earned $921 million during the quarter, compared to the consensus estimate of $873.50 million. During the same period in the prior year, the firm earned $1.08 EPS. The company’s revenue was up 25.3% compared to the same quarter last year. On average, analysts predict that Endo International PLC will post $4.56 EPS for the current fiscal year.
About Endo International PLC
Endo International PLC, formerly Endo Health Solutions Inc is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel.
Receive News & Ratings for Endo International PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International PLC and related companies with MarketBeat.com's FREE daily email newsletter.